- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/39 - PancreasIslets of Langerhans
Patent holdings for IPC class A61K 35/39
Total number of patents in this class: 856
10-year publication summary
|
71
|
73
|
77
|
92
|
79
|
76
|
86
|
76
|
68
|
38
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ViaCyte, Inc. | 178 |
37 |
| Vertex Pharmaceuticals Incorporated | 1595 |
36 |
| Children's Medical Center Corporation | 1863 |
28 |
| Janssen Biotech, Inc. | 1552 |
21 |
| President and Fellows of Harvard College | 5973 |
20 |
| The Regents of the University of California | 19943 |
19 |
| Sana Biotechnology, Inc. | 158 |
17 |
| Massachusetts Institute of Technology | 10057 |
15 |
| CRISPR Therapeutics AG | 365 |
15 |
| City of Hope | 994 |
14 |
| Cornell University | 3307 |
11 |
| RegenLab USA LLC | 76 |
11 |
| Regents of the University of Minnesota | 2696 |
10 |
| Seraxis, Inc. | 18 |
10 |
| Wake Forest University Health Sciences | 721 |
10 |
| Yeda Research and Development Co. Ltd. | 1343 |
10 |
| Accelerated Biosciences Corp. | 39 |
9 |
| The Salk Institute for Biological Studies | 446 |
9 |
| University of Louisville Research Foundation, Inc. | 720 |
9 |
| Orgenesis Ltd. | 12 |
8 |
| Other owners | 537 |